熱門資訊> 正文

Thomus报告第一季度业绩

2026-05-11 20:54

安帝君斯(AGEN) 0

Agenus press release (AGEN): Q1 Cash and cash equivalents totaled $35.0 million as of March 31, 2026, compared with $3.0 million as of December 31, 2025.
The company also expects to collect outstanding receivables under regulatory-authorized early access programs during the second quarter of 2026.

More on Agenus

Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript
Agenus Q4 2025 Earnings Preview
GSK wins FDA label expansion for RSV vaccine, Arexvy
Seeking Alpha’s Quant Rating on Agenus
Historical earnings data for Agenus

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。